Global market for multiple sclerosis disease-modifying products to reach $14.2 billion by 2018

Disease-modifying agents to treat multiple sclerosis (MS) are currently one of the largest classes of pharmaceutical products by sales in the U.S. and throughout the world. The total worldwide market for MS disease-modifying therapies is expected to reach nearly $14.2 billion by the end of 2018. The U.S. will be the primary market for most… Read More Global market for multiple sclerosis disease-modifying products to reach $14.2 billion by 2018

Global HIV therapeutics market to reach $19.6 billion by 2018

Advanced treatment options and improved methods of diagnosis have helped to moderate the growth of HIV/AIDS. However, there is an ongoing, urgent need for the development of new therapeutics and diagnostic products, as well as proper exploitation of existing options. R&D spending, patent expiries, and improving access to healthcare will shape growth in this market… Read More Global HIV therapeutics market to reach $19.6 billion by 2018

Global neurostimulation devices market to reach $4.1 billion by 2018

It is estimated that over 100 million people globally suffer from chronic pain annually. While drug therapies are the primary treatment option, neurostimulation devices are increasingly used for pain management. Increasing acceptance of neurostimulation devices for multiple applications, an aging population, and technological advancements, as well as negative factors such as device recalls will shape… Read More Global neurostimulation devices market to reach $4.1 billion by 2018

Global markets for histone deacetylase inhibitors to reach $954.3 million by 2018

Histone deacetylase inhibitors (HDIs) are promising therapeutics that have already shown potential for oncological applications such as cancer detection, diagnosis, and prognosis. Current candidates are demonstrating successful pre-clinical and clinical trials for various other diseases such as neurological ailments, heart diseases, HIV infections, and many others. Prospective pipeline products, collaborations and joint ventures, focused researches,… Read More Global markets for histone deacetylase inhibitors to reach $954.3 million by 2018

Global markets for advanced drug delivery systems to reach nearly $212.8 billion by 2018

Advanced drug delivery systems offer many advantages, including improved therapy by increasing the efficacy and duration of drug activity, decreased dosing frequency, convenient routes of administration, and improved targeting for a specific site to reduce unwanted side effects. Increasing R&D spending, along with increasing competition, patent expiries, and new technologies will continue to shape growth… Read More Global markets for advanced drug delivery systems to reach nearly $212.8 billion by 2018

Global markets for machine vision (MV) system components to reach $23.5 billion by 2019

Advances in machine vision technology, including smart cameras and vision-guided robotics, have increased the scope of the market for MV systems components, leading to wider application across all sectors of the economy. Increasing consumer demand for smaller, smarter devices; technological advances in quality control; and significant reductions in production costs will spur tremendous growth in… Read More Global markets for machine vision (MV) system components to reach $23.5 billion by 2019

Global Markets For Smoking Cessation Medicine To Reach $2.5 Billion By 2018

The growing consumption of cigarettes in developing and poor countries is increasing the mortality rate and health hazards associated with smoking. In addition, the demand for smoking cessation medicines has grown substantially in the developed markets of North America and Europe. These conditions are expected to drive the market for smoking cessation medicines in both… Read More Global Markets For Smoking Cessation Medicine To Reach $2.5 Billion By 2018

Predicts Regenerative Medicines Market for Bone and Joint Applications to Reach $3.9 Billion by 2018

In the new report, Regenerative Medicines: Bone and Joint Applications (Report Code: PHM032C), from BCC Research (http://www.bccresearch.com), the regenerative medicines market for bone and joint applications was valued at $2.72 billion in 2012 and is expected to reach $2.72 billion in 2013. The report forecasts total market value to reach $3.9 billion in 2018, after… Read More Predicts Regenerative Medicines Market for Bone and Joint Applications to Reach $3.9 Billion by 2018

Orphan Drug Market to Reach $112 Billion in 2017

In the new report, GLOBAL MARKETS FOR ORPHAN DRUGS (PHM038D), from BCC Research (http://www.bccresearch.com), the global market for orphan drugs was valued at $82.6 billion in 2011 and nearly $86 billion in 2012. The report forecasts total market value to reach $112 billion in 2017, after increasing at a five-year compound annual growth rate (CAGR)… Read More Orphan Drug Market to Reach $112 Billion in 2017

The Global Market for Histone Methyltransferases Research and Development is Expected to Reach Nearly $275 Million in 2018

The overall market for HMT research and discovery is still in a premature state and can be divided into three main segments: research tools, drug discovery and diagnostics.The research tools sector is the most developed niche and is represented both by well-established and small biotech companies. It was estimated at around $30 million in the… Read More The Global Market for Histone Methyltransferases Research and Development is Expected to Reach Nearly $275 Million in 2018